Search research articles
Contact Us
Filters
Showing results (201-210 of 241) with videos related to
Page
of 25
Sort By:
Plos One
|
January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine
Sandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
Stem Cell Reports
|
October 13, 2021
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2
Liuliu Yang, Benjamin E Nilsson-Payant, Yuling Han, et al.
Nature
|
July 23, 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu, Pengfei Wang, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology
|
June 27, 2020
Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike
Lihong Liu, Pengfei Wang, Manoj S Nair, et al.
Nature
|
January 11, 2022
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Plos One
|
May 24, 2011
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers
Sandhya Vasan, Arlene Hurley, Sarah J Schlesinger, et al.
Molecular Systems Biology
|
January 6, 2025
A multiplex method for rapidly identifying viral protease inhibitors
Seo Jung Hong, Samuel J Resnick, Sho Iketani, et al.
Cell Host & Microbe
|
December 3, 2020
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
Tongqing Zhou, Yaroslav Tsybovsky, Jason Gorman, et al.
Elife
|
November 16, 2022
Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study
James A Hay, Stephen M Kissler, Joseph R Fauver, et al.
Plos One
|
January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
Sandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, et al.
Page
of 25
Search research articles
Search
Showing results (201-210 of 241) with videos related to
Sort By:
Page
of 25
Plos One
|
January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADVAX, a multigenic, DNA-based clade C/B' HIV-1 candidate vaccine
Sandhya Vasan, Sarah J Schlesinger, Yaoxing Huang, et al.
Stem Cell Reports
|
October 13, 2021
Cardiomyocytes recruit monocytes upon SARS-CoV-2 infection by secreting CCL2
Liuliu Yang, Benjamin E Nilsson-Payant, Yuling Han, et al.
Nature
|
July 23, 2020
Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike
Lihong Liu, Pengfei Wang, Manoj S Nair, et al.
Biorxiv : the Preprint Server for Biology
|
June 27, 2020
Potent Neutralizing Antibodies Directed to Multiple Epitopes on SARS-CoV-2 Spike
Lihong Liu, Pengfei Wang, Manoj S Nair, et al.
Nature
|
January 11, 2022
Striking antibody evasion manifested by the Omicron variant of SARS-CoV-2
Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Plos One
|
May 24, 2011
In vivo electroporation enhances the immunogenicity of an HIV-1 DNA vaccine candidate in healthy volunteers
Sandhya Vasan, Arlene Hurley, Sarah J Schlesinger, et al.
Molecular Systems Biology
|
January 6, 2025
A multiplex method for rapidly identifying viral protease inhibitors
Seo Jung Hong, Samuel J Resnick, Sho Iketani, et al.
Cell Host & Microbe
|
December 3, 2020
Cryo-EM Structures of SARS-CoV-2 Spike without and with ACE2 Reveal a pH-Dependent Switch to Mediate Endosomal Positioning of Receptor-Binding Domains
Tongqing Zhou, Yaroslav Tsybovsky, Jason Gorman, et al.
Elife
|
November 16, 2022
Quantifying the impact of immune history and variant on SARS-CoV-2 viral kinetics and infection rebound: A retrospective cohort study
James A Hay, Stephen M Kissler, Joseph R Fauver, et al.
Plos One
|
January 30, 2010
Phase 1 safety and immunogenicity evaluation of ADMVA, a multigenic, modified vaccinia Ankara-HIV-1 B'/C candidate vaccine
Sandhya Vasan, Sarah J Schlesinger, Zhiwei Chen, et al.
Page
of 25